Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients

被引:43
|
作者
Miura, Masatomo [1 ]
Satoh, Shigeru [2 ]
Inoue, Kazuyuki [1 ]
Kagayaa, Hideaki [1 ]
Saito, Mitsuru [2 ]
Inoue, Takamitsu [2 ]
Habuchi, Tomonori [2 ]
Suzuki, Toshio [1 ]
机构
[1] Akita Univ Hosp, Dept Pharm, Akita 0108543, Japan
[2] Akita Univ, Sch Med, Dept Urol, Akita 010, Japan
基金
日本学术振兴会;
关键词
prednisolone; tacrolimus; CYP3A5; P-glycoprotein; pregnane X receptor;
D O I
10.1016/j.steroids.2008.04.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this study was to evaluate whether genetic polymorphisms of CYP3A5 (A6986G, CYP3A5*3), ABCB1 (C1236T, G2677T/A, C3435T) and NR1I2 (A7635G) significantly impact the pharmacokinetics of prednisolone in renal transplant recipients. Ninety-five recipients were given repeated doses of triple therapy immunosuppression consisting of prednisolone, tacrolimus and mycophenolate mofetil. Twenty-eight days after renal transplantation, plasma prednisolone concentrations were measured by high-performance liquid chromatography. Comparisons of the CYP3A5 and ABCB1 genotypes revealed no significant differences in the prednisolone pharmacokinetics. The mean prednisolone C-max for recipients (n = 14) having both the ABCB1 3435CC genotype and the CYP3A5*3/*3 genotype was significantly higher than those (n = 11) having both ABCB1 3435TT and CYP3A5*3/*3 genotypes (180 ng/mL versus 129 ng/mL, P = 0.0392). The plasma concentrations of prednisolone in recipients having both ABCB1 3435CC and CYP3A5*3/*3 genotypes tended to be higher than those having both ABCB1 3435TT and CYP3A5*3/*3 genotypes. The mean AUC(0-24) and C.. values for prednisolone in recipients having the NR1I2 7635G allele (AG: n = 45, GG: n = 32) were significantly lower than in patients having the 7635AA allele (n = 18) (7635GG versus 7635AA, P = 0.0308 for AUC(0-24), P = 0.0382 for C-max of prednisolone). In conclusion, NR1I2 (A7635G) rather than CYP3A5 or ABCB1 allelic variants affected patient variability of plasma prednisolone concentration. Recipients carrying the NR1I2 7635G allele seemed to possess higher metabolic activity for prednisolone in the intestine, greatly reducing its maximal plasma concentration. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1052 / 1059
页数:8
相关论文
共 50 条
  • [31] Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy
    Junichi Nakagawa
    Takenori Takahata
    Yu Chen
    Kensuke Saito
    Kosuke Kamata
    Takuto Tachita
    Satoru Yamashita
    Keigo Saito
    Kayo Ueno
    Atsushi Sato
    Hirotake Sakuraba
    Takenori Niioka
    Cancer Chemotherapy and Pharmacology, 2023, 92 (5) : 391 - 398
  • [32] Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy
    Nakagawa, Junichi
    Takahata, Takenori
    Chen, Yu
    Saito, Kensuke
    Kamata, Kosuke
    Tachita, Takuto
    Yamashita, Satoru
    Saito, Keigo
    Ueno, Kayo
    Sato, Atsushi
    Sakuraba, Hirotake
    Niioka, Takenori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, : 391 - 398
  • [33] Interactive effects of CYP3A4, CYP3A5, MDR1 and NR1I2 polymorphisms on tracrolimus trough concentrations in early postrenal transplant recipients
    Li, Jia-li
    Liu, Shu
    Fu, Qian
    Zhang, Yu
    Wang, Xue-ding
    Liu, Xiao-man
    Liu, Long-shan
    Wang, Chang-xi
    Huang, Min
    PHARMACOGENOMICS, 2015, 16 (12) : 1355 - 1365
  • [34] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 618 - 618
  • [35] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    TRANSPLANTATION, 2014, 98 : 618 - 618
  • [36] Association of polymorphisms in NR1I2 and ABCB1 genes with epilepsy treatment responses
    Hung, Chin-Chuan
    Tai, John Jen
    Kao, Pi-Ju
    Lin, Min-Sbung
    Liou, HornHuei
    PHARMACOGENOMICS, 2007, 8 (09) : 1151 - 1158
  • [37] POLIMORPHISMS IN THE CYP3A4, CYP3A5 AND ABCB1 GENES MODIFY TACROLIMUS PHARMACOKINETICS AND PHARMACODYNAMICS IN RENAL TRANSPLANT
    Garcia, M.
    Macias, R. M.
    Caravaca, F.
    Benitez, J.
    Cubero, J.
    Carrillo, J. A.
    Gervasini, G.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 64 - 64
  • [38] Association of CYP3A5, CYP2C8, and ABCB1 Polymorphisms With Early Renal Injury in Chinese Liver Transplant Recipients Receiving Tacrolimus
    Deng, R.
    Liao, Y.
    Li, Yi
    Tang, J.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3258 - 3265
  • [39] EFFECT OF CYP3A5, CYP3A4, POR AND ABCB1 POLYMORPHISMS ON TACROLIMUS METABOLISM IN RENAL TRANSPLANT PATIENTS
    Chong, Winnie
    Hamilton-Jones, Siobhan
    Kim, Jon Jin
    Navarrete, Cristina V.
    Key, Tim
    Howell, Martin W.
    HLA, 2020, 95 (04) : 316 - 316
  • [40] Association study of ABCB1 and CYP3A5 gene polymorphisms with sirolimus trough concentration and dose requirements in Chinese renal transplant recipients
    Miao, Li-Yan
    Huang, Chen-Rong
    Hou, Jian-Quan
    Qian, Mei-Ying
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2008, 29 (01) : 1 - 5